Bicara Therapeutics (BCAX) Financials: Revenue & Earnings

BCAX price $9.97 -7.51 -42.96%

Ticker
BCAX
Price
$9.97
Change
-7.51 -42.96%
Market cap ?
$659.84M
Beta ?
-0.82
Sector
Healthcare
Industry
Biotechnology

Fair value

BCAX fair value $41.48. Price $9.97. Price is 76% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare BCAX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.84——
2026-08-11-0.82-0.82——
2026-05-11-0.93-0.64——
2026-03-26-0.68-0.72——
2025-11-10-0.67-0.55——
2025-08-12-0.50-0.54——
2025-05-13-0.68-0.40——
2025-03-27-0.39-0.31——
2024-11-12-1.60-0.46——
2024-09-13-0.45———
2023-12-31-0.23———
2023-09-30-0.42———
2023-06-30-0.15———
2023-03-31-0.15———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-08Cohlhepp RyanBuy17.50K$3.7966.32K
2026-09-08Cohlhepp RyanSell14.06K$22.77320.05K
2026-09-08Cohlhepp RyanSell3.44K$23.4380.66K
2026-09-08Cohlhepp RyanSell17.50K$3.7966.32K
2026-08-12Larson JenniferBuy285.00K$24.637.02M
2026-08-12Larson JenniferOther0——
2026-08-10Hyep IvanBuy12.50K$3.7947.37K
2026-08-10Hyep IvanSell12.50K$27.97349.59K
2026-08-10Hyep IvanSell12.50K$3.7947.37K
2026-08-10Mazumdar ClaireBuy10.00K$3.7937.90K
2026-08-10Mazumdar ClaireSell10.00K$27.98279.75K
2026-08-10Mazumdar ClaireSell10.00K$3.7937.90K
2026-08-10Cohlhepp RyanBuy18.75K$3.7971.06K
2026-08-10Cohlhepp RyanSell18.75K$27.98524.53K
2026-08-10Cohlhepp RyanSell18.75K$3.7971.06K
2026-07-28Bender JeremyBuy38.95K$26.881.05M
2026-07-28Oliger Christy J.Buy38.95K$26.881.05M
2026-07-28Bender JeremyOther0——
2026-07-28Oliger Christy J.Other0——
2026-07-10Mazumdar ClaireBuy10.00K$3.7937.90K
2026-07-10Mazumdar ClaireSell9.97K$28.42283.37K
2026-07-10Mazumdar ClaireSell28$29.68831
2026-07-10Mazumdar ClaireSell10.00K$3.7937.90K
2026-07-09Cohlhepp RyanSell536$29.0015.54K
2026-07-08Cohlhepp RyanBuy18.75K$3.7971.06K
2026-07-08Cohlhepp RyanSell22.83K$28.76656.65K
2026-07-08Cohlhepp RyanSell4.31K$29.80128.30K
2026-07-08Cohlhepp RyanSell1.07K$30.3532.63K
2026-07-08Cohlhepp RyanSell18.75K$3.7971.06K
2026-07-08Hyep IvanBuy12.50K$3.7947.37K
2026-07-08Hyep IvanSell22.76K$28.60650.90K
2026-07-08Hyep IvanSell4.41K$29.82131.62K
2026-07-08Hyep IvanSell830$30.3125.16K
2026-07-08Hyep IvanSell11.59K$3.7943.93K
2026-07-08Hyep IvanSell908$3.793.44K
2026-06-09RA CAPITAL MANAGEMENT, L.P.Buy19.48K$20.56400.41K
2026-06-09Bowden ChristopherBuy19.48K$20.56400.41K
2026-06-09Haviland KateBuy19.48K$20.56400.41K
2026-06-09Mazumdar-Shaw KiranBuy19.48K$20.56400.41K
2026-06-09Robertson Scott M.Buy19.48K$20.56400.41K
2026-06-09POWELL MICHAELBuy19.48K$20.56400.41K
2026-06-09Simson JakeBuy19.48K$20.56400.41K
2026-05-21Hyep IvanBuy9.20K$3.7934.87K
2026-05-21Hyep IvanSell9.20K$20.42187.88K
2026-05-21Hyep IvanSell9.20K$3.7934.87K
2026-05-18Mazumdar ClaireBuy15.00K$3.7956.85K
2026-05-18Mazumdar ClaireSell12.02K$19.96239.98K
2026-05-18Mazumdar ClaireSell2.98K$20.3560.60K
2026-05-18Mazumdar ClaireSell15.00K$3.7956.85K
2026-05-15Cohlhepp RyanBuy8.00K$3.7930.32K
2026-05-15Cohlhepp RyanSell8.00K$20.29162.34K
2026-05-15Cohlhepp RyanSell4.50K$20.2991.31K
2026-05-15Cohlhepp RyanSell8.00K$3.7930.32K
2026-05-08Schelman WilliamBuy85.00K$22.581.92M
2026-05-08Schelman WilliamOther150.00K$16.612.49M
2026-05-08Schelman WilliamOther25.00K$16.76419.00K
2026-04-27Raben DavidBuy5.50K$3.7920.84K
2026-04-27Raben DavidSell5.50K$22.88125.83K
2026-04-27Raben DavidSell5.50K$3.7920.84K
2026-04-21Hyep IvanBuy9.20K$3.7934.87K
2026-04-21Hyep IvanSell9.20K$23.00211.61K
2026-04-21Hyep IvanSell9.20K$3.7934.87K
2026-04-20Mazumdar ClaireBuy15.00K$3.7956.85K
2026-04-20Mazumdar ClaireSell15.00K$23.61354.15K
2026-04-20Mazumdar ClaireSell15.00K$3.7956.85K
2026-04-16Mazumdar ClaireSell7.08K$5.4538.61K
2026-04-16Mazumdar ClaireBuy7.08K$5.4538.61K
2026-04-16Mazumdar ClaireBuy7.45K$3.7928.25K
2026-04-16Mazumdar ClaireBuy8.23K$4.4436.50K
2026-04-16Mazumdar ClaireSell7.45K$3.7928.25K
2026-04-16Mazumdar ClaireSell8.23K$4.4436.50K
2026-04-15Cohlhepp RyanBuy8.00K$3.7930.32K
2026-04-15Cohlhepp RyanSell8.00K$23.01184.06K
2026-04-15Cohlhepp RyanSell4.50K$23.01103.53K
2026-04-15Cohlhepp RyanSell8.00K$3.7930.32K
2026-03-25Raben DavidBuy5.50K$3.7920.84K
2026-03-25Raben DavidSell5.50K$18.95104.23K
2026-03-25Raben DavidSell5.50K$3.7920.84K
2026-03-23Hyep IvanBuy9.20K$3.7934.87K
2026-03-23Hyep IvanSell9.20K$18.52170.35K
2026-03-23Hyep IvanSell9.20K$3.7934.87K
2026-03-20Mazumdar ClaireBuy1.60K$3.796.05K
2026-03-20Mazumdar ClaireSell1.60K$18.9530.25K
2026-03-20Mazumdar ClaireSell1.60K$3.796.05K
2026-03-19Mazumdar ClaireBuy6.91K$3.7926.17K
2026-03-19Mazumdar ClaireSell6.91K$18.78129.70K
2026-03-19Mazumdar ClaireSell6.91K$3.7926.17K
2026-03-18Mazumdar ClaireBuy6.50K$3.7924.63K
2026-03-18Mazumdar ClaireSell6.50K$18.84122.41K
2026-03-18Mazumdar ClaireSell6.50K$3.7924.63K
2026-03-16Cohlhepp RyanBuy8.00K$3.7930.32K
2026-03-16Cohlhepp RyanSell8.00K$19.66157.26K
2026-03-16Cohlhepp RyanSell4.50K$19.6688.46K
2026-03-16Cohlhepp RyanSell8.00K$3.7930.32K
2026-03-06Mazumdar ClaireBuy3.82K$3.7914.47K
2026-03-06Mazumdar ClaireSell3.82K$18.7571.57K
2026-03-06Mazumdar ClaireSell3.82K$3.7914.47K
2026-03-05Mazumdar ClaireBuy1.79K$3.796.77K
2026-03-05Mazumdar ClaireSell1.79K$18.7433.46K
2026-03-05Mazumdar ClaireSell1.79K$3.796.77K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 183, holders +29 vs prior quarter. Ownership 119.50%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.7.26M00.00%215.43M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.6.34M-267.29K-4.05%188.19M
SIREN, L.L.C.5.60M-200.00K-3.45%166.35M
VESTAL POINT CAPITAL, LP5.25M-175.00K-3.23%155.87M
DEEP TRACK CAPITAL, LP4.10M37.50K+0.92%121.73M
BLACKROCK, INC.3.85M1.00M+35.32%114.25M
JUPITER TOPCO LLC3.17M3.17MNew93.96M
RED TREE MANAGEMENT, LLC3.16M-6.99K-0.22%93.92M
TPG GP A, LLC3.01M00.00%89.38M
VANGUARD CAPITAL MANAGEMENT LLC2.22M442.42K+24.94%65.81M
STATE STREET CORP2.05M629.53K+44.35%60.83M
ROYALTY PHARMA SUB-MANAGER, LLC2.39M00.00%60.61M
FRANKLIN TEMPLETON INC1.95M330.25K+20.37%57.95M
PRICE T ROWE ASSOCIATES INC /MD/1.90M528.05K+38.37%56.54M
FMR LLC1.89M-207.86K-9.89%56.21M
OMEGA FUND MANAGEMENT, LLC1.82M-570.00K-23.83%54.10M
GEODE CAPITAL MANAGEMENT, LLC1.16M331.73K+39.92%34.53M
JPMORGAN CHASE & CO1.02M838.56K+472.67%29.81M
JONES HILL CAPITAL LP892.62K-367.51K-29.16%26.50M
ACORN CAPITAL ADVISORS, LLC643.38K-1-0.00%19.10M
AISLING CAPITAL MANAGEMENT LP568.92K00.00%16.89M
PALO ALTO INVESTORS LP550.41K00.00%16.34M
ROCK SPRINGS CAPITAL MANAGEMENT LP535.29K46.19K+9.44%15.89M
GOLDMAN SACHS GROUP INC520.57K-38.40K-6.87%15.46M
D. E. SHAW & CO., INC.498.19K221.25K+79.89%14.79M

Earnings and financials

Bicara Therapeutics Inc. Common Stock (BCAX) trades at $9.97, with a market cap of $659.84M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Bicara Therapeutics (BCAX) Financials: Revenue & Earnings

BCAX$9.97-7.51 -42.96%

$659.84M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History